Physician profile
Joyce Chung
NPI 1851944821
$1,175.01
in general payments reported to CMS, 2019-2025
12 companies · $500 in 2025
The $500 reported for 2025 was more than what 77% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $250 · 2024: $426 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,175.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $209.78 | 2023-2024 | Farxiga |
| Ardelyx, INC. | $188.57 | 2024-2025 | Xphozah 30 Mg, Ibsrela |
| Bayer Healthcare Pharmaceuticals INC. | $171.52 | 2023-2025 | |
| Amgen INC. | $125.00 | 2025 | Tavneos |
| Insulet Corporation | $99.38 | 2024 | Omnipod |
| Calliditas Therapeutics US INC. | $97.46 | 2024-2025 | Tarpeyo |
| Novartis Pharmaceuticals Corporation | $86.95 | 2024-2025 | |
| Novo Nordisk INC | $66.90 | 2024-2025 | Ozempic, Rivfloza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.99 | 2024-2025 | Jardiance |
| Averitas Pharma INC. | $30.00 | 2024 | Qutenza |
| Fresenius USA Marketing, INC. | $28.53 | 2024 | Velphoro |
| Otsuka America Pharmaceutical, INC. | $19.93 | 2024 | Jynarque |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.